Michelle D. Po, PhD

Delayed-release and extended-release methylphenidate (DR/ER-MPH) has shown marked improvement in ADHD symptoms and functional impairment. This post hoc analysis examined response and remission thresholds for DR/ER-MPH in the context...

Methylphenidate is related to sleep-related adverse events. This meta-analysis sought to quantify this impact of methylphenidate and determine the varieties of sleep problems associated with this drug.